Assure Exceeds Fourth Quarter 2021 Forecast for Remote Neurology Managed Cases
DENVER, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider...
Month: January 2022
Nemaura Medical Launches Metabolic Health Program for Employers and Insurers
Launch into commercial markets offers opportunities for faster and wider adoption of Miboko program Loughborough, England, Jan. 13, 2022 (GLOBE...
POAI Reports Strong Results From Its AI Cancer Drug Evaluation
MINNEAPOLIS, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) reported the preliminary results of its Discovery 2021...
vTv Therapeutics Shares Updated Corporate Presentation
HIGH POINT, N.C., Jan. 13, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company committed to...
Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring...
Clearmind Medicine’s VP of Business Development Presented at The Canadian Psychedelics Association Event
The CPA's Panel for physicians and medical professionals addressed "New Psychedelic Substances" TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Clearmind...
Rockwell Medical Announces Regulatory Approval of Triferic® AVNU in South Korea
-Commercial launch expected in June/July 2022- -Rockwell Medical has an exclusive license agreement with Jeil Pharmaceutical Co., Ltd., for the...
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
Revenues up 239% over prior year fiscal second quarter Customer orders backlog of over $4.0 million at November 30, 2021...
SmileDirectClub Partners With Jonathan Van Ness, Tunde Oyeneyin and Arielle Vandenberg To Launch New Confidence Council, Highlighting the Transformational Power of a Smile
93% agree that a straight and healthy smile increases self-confidence.* Jonathan Van Ness SmileDirectClub Confidence Council Ambassador Tunde Oyeneyin SmileDirectClub...
Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System
Powered by novel technology that can map a million cells in 10 minutes, the system enables unbiased spatial discovery across...
aTyr Pharma Advances Development of Lead Therapeutic Candidate ATYR1923 with Announcement of “efzofitimod” as Nonproprietary Name
Efzofitimod expected to enter into a registrational trial for pulmonary sarcoidosis in 2022SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) --...
Piezo Motion, STXi Motion join forces to disrupt the precision motor market in Israel
Piezo Motion to deliver cost-effective industrial automation solutions to STXi’s customersNEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via InvestorWire...
An exciting joining of forces to support the Lachine Hospital!
Lachine Hospital Foundation is integrating with the McGill University Health Centre Foundation for a bigger impact Joining Forces to Support...
Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) Application
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a...
CinCor Pharma Appoints June Lee to Its Board of Directors
BOSTON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced the appointment of the independent member...
BlueJay Therapeutics to Present at the 2nd Global IR@JPM Conference
SAN MATEO, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- BlueJay Therapeutics, a private biopharmaceutical company focused on cures for infectious...
Ascend Expands Testing Capacity with New Siemens Healthineers Strategic Relationship
The nation’s leading dialysis testing lab will become the biggest single-site user of Siemens Healthineers Atellica Solution analyzers in the...
Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial of RTX-224, a Broad Immune Agonist, for the Treatment of Certain Solid Tumors
CAMBRIDGE, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically...
Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Growth Hormone Deficiency
TransCon hGH (approved by the European Commission as Lonapegsomatropin Ascendis Pharma) is a once-weekly prodrug of somatropin for pediatric patients...
AmoyDx and PREMIA Announce the Commercial Launch of the AmoyDx® Pan Lung Cancer PCR Panel in Japan
XIAMEN, China and HONG KONG, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Amoy Diagnostics Co., Ltd., (“AmoyDx”) and PREMIA Holdings (HK)...
